Literature DB >> 29544142

Anxiety sensitivity and cannabis use problems, perceived barriers for quitting, and fear of quitting.

Michael J Zvolensky1, Andrew H Rogers2, Kara Manning2, Julianna B D Hogan3, Daniel J Paulus2, Julia D Buckner4, Nubia A Mayorga2, Gerald Hallford2, Norman B Schmidt5.   

Abstract

Cannabis is among the most widely used psychoactive substances in the United States, and rates of cannabis use and cannabis-related problems are increasing. Anxiety sensitivity, or the fear of aversive interoceptive sensations, may be relevant to better understanding cannabis use problems and other significant cannabis use processes (e.g., beliefs about quitting). Previous research has primarily focused on the global anxiety sensitivity construct; however, anxiety sensitivity lower-order facets (Cognitive Concerns, Physical Concerns, and Social Concerns) tend to be differentially related to substance use processes in non-cannabis specific studies. The current study therefore explored anxiety sensitivity lower-order facets in relation to cannabis use problems, perceived barriers for cannabis cessation, and abstinence phobia (fear of not using cannabis) among a community sample of 203 cannabis-using adults. Results indicated that anxiety sensitivity Cognitive Concerns were significantly associated with each of the dependent measures and these effects were not explained by shared variance with the other lower-order factors or a range of other covariates (e.g., tobacco use). The present findings suggest future work may benefit from focusing on the role of anxiety sensitivity Cognitive Concerns in the maintenance of cannabis use.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Barriers for quitting; Cannabis; Cannabis use; Substance use

Mesh:

Year:  2018        PMID: 29544142     DOI: 10.1016/j.psychres.2018.03.006

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.

Authors:  Julia D Buckner; Michael J Zvolensky; Anthony H Ecker; Norman B Schmidt; Elizabeth M Lewis; Daniel J Paulus; Paula Lopez-Gamundi; Kathleen A Crapanzano; Jafar Bakhshaie
Journal:  Behav Res Ther       Date:  2018-10-26

Review 2.  Interoceptive anxiety-related processes: Importance for understanding COVID-19 and future pandemic mental health and addictive behaviors and their comorbidity.

Authors:  Michael J Zvolensky; Brooke Y Kauffman; Lorra Garey; Andres G Viana; Cameron T Matoska
Journal:  Behav Res Ther       Date:  2022-06-18

3.  Effects of cannabis use on alcohol consumption in a sample of treatment-engaged heavy drinkers in Colorado.

Authors:  Hollis C Karoly; J Megan Ross; Mark A Prince; Alexandra E Zabelski; Kent E Hutchison
Journal:  Addiction       Date:  2021-01-26       Impact factor: 7.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.